Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression
暂无分享,去创建一个
D. Mehta | E. Binder | Andrew H. Miller | C. Raison | E. Haroon | J. Felger | B. Woolwine